<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--/tmp/30465.pmc.30465/meta_CAN9485.xml-->
  <!---->
  <?origin publisher?>
  <?FILEmeta_CAN9485 xml ?>
  <?FILEmain xml ?>
  <?FILEgr1 jpg ?>
  <?FILEgr2 jpg ?>
  <?FILEgr3 jpg ?>
  <?FILEgr4 jpg ?>
  <?FILEmmc1 doc ?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cancer Lett</journal-id>
      <journal-title>Cancer Letters</journal-title>
      <issn pub-type="ppub">0304-3835</issn>
      <issn pub-type="epub">1872-7980</issn>
      <publisher>
        <publisher-name>Elsevier Science Ireland</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2580815</article-id>
      <article-id pub-id-type="pmid">18657901</article-id>
      <article-id pub-id-type="publisher-id">CAN9485</article-id>
      <article-id pub-id-type="doi">10.1016/j.canlet.2008.06.014</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A stem cell gene expression profile of human squamous cell carcinomas</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jensen</surname>
            <given-names>Kim B.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jones</surname>
            <given-names>Judith</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Watt</surname>
            <given-names>Fiona M.</given-names>
          </name>
          <email>fiona.watt@cancer.org.uk</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="aff3" ref-type="aff">c</xref>
          <xref rid="cor1" ref-type="corresp">&#x204E;</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <addr-line><sup>a</sup>Wellcome Trust Centre for Stem Cell Research, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QR, United Kingdom</addr-line>
      </aff>
      <aff id="aff2">
        <addr-line><sup>b</sup>Department of Oral &amp; Maxillofacial Surgery, Guy&#x2019;s Hospital, London SE1 9RT, United Kingdom</addr-line>
      </aff>
      <aff id="aff3">
        <addr-line><sup>c</sup>CR UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, United Kingdom</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1"><label>&#x204E;</label>Corresponding author. Address: Wellcome Trust Centre for Stem Cell Research, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QR, United Kingdom. Tel.: +44 1223 760246; fax: +44 1223 760287. <email>fiona.watt@cancer.org.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>08</day>
        <month>12</month>
        <year>2008</year>
      </pub-date>
      <volume>272</volume>
      <issue>1</issue>
      <fpage>23</fpage>
      <lpage>31</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>4</month>
          <year>2008</year>
        </date>
        <date date-type="rev-recd">
          <day>8</day>
          <month>6</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>8</day>
          <month>6</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2008 Elsevier Ireland Ltd.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <copyright-holder>Elsevier Ireland Ltd</copyright-holder>
        <license>
          <p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <p>To investigate the relationship between stem cells in normal epithelium and in squamous cell carcinomas (SCCs), we examined expression of a panel of human epidermal stem cell markers in SCCs and SCC cell lines. Markers that are co-expressed in normal stem cells were not co-expressed in SCC. Downregulation of two markers, Lrig1 and MAP4, and upregulation of a third, MCSP, correlated with poor differentiation status and increased proliferation in primary tumours. We conclude that SCCs do not reflect a simple expansion of stem cells; rather, tumour cells hijack the homeostatic controls that operate in normal stem cells, eliminating those that maintain stem cell quiescence.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Squamous cell carcinoma</kwd>
        <kwd>Stem cells</kwd>
        <kwd>Epidermis</kwd>
        <kwd>Keratinocyte</kwd>
        <kwd>Cancer stem cell</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <label>1</label>
      <title>Introduction</title>
      <p>Stratified squamous epithelia act as a protective interface between the body and the environment. They have a simple organisation: proliferation takes place in the basal layer of cells attached to an underlying basement membrane, and cells undergo terminal differentiation as they move towards the tissue surface <xref rid="bib1" ref-type="bibr">[1]</xref>. The outermost cell layers are shed throughout adult life and are replaced through proliferation of a subpopulation of cells in the basal layer known as stem cells <xref rid="bib1" ref-type="bibr">[1]</xref>. Examples of stratified squamous epithelia are the epidermis, the lining of the oral cavity, the cervix and oesophagus.</p>
      <p>One of the characteristic tumours of stratified squamous epithelia is squamous cell carcinoma (SCC). These tumours retain hallmarks of the normal epithelial terminal differentiation programme; however, proliferation is increased, the proportion of differentiated cells is decreased, and the spatial organisation of the cell layers is disrupted <xref rid="bib1" ref-type="bibr">[1]</xref>. There is evidence that SCCs are maintained by a subpopulation of proliferative cells termed cancer stem cells, which are responsible for tumour maintenance and for regrowth following conventional treatment <xref rid="bib2 bib3" ref-type="bibr">[2,3]</xref>.</p>
      <p>At present little is known about the relationship between stem cells in normal stratified squamous epithelia and stem cells in SCCs. However, it is generally believed that oncogenic changes in stem cells are responsible for SCC development because stem cells are the only long-lived cells within stratified epithelia <xref rid="bib1" ref-type="bibr">[1]</xref>. We recently generated single cell cDNA libraries from normal human epidermal cells and used them to identify a panel of 14 stem cell markers <xref rid="bib4" ref-type="bibr">[4]</xref>. In the present report, we have investigated their expression in SCC, with a view to discovering the relationship between stem cells in normal stratified squamous epithelia and SCC.</p>
    </sec>
    <sec sec-type="materials|methods">
      <label>2</label>
      <title>Materials and methods</title>
      <sec>
        <label>2.1</label>
        <title>Cell culture conditions and stem cell fractionation</title>
        <p>Primary human keratinocytes from neonatal foreskin (strains kj, kt and kw), adult oral mucosa (strain OK) and the SCC lines SCC9, SCC12B.2, SCC13, SCC15, SCC25, SCC27 <xref rid="bib5 bib6" ref-type="bibr">[5,6]</xref> and H376 <xref rid="bib7" ref-type="bibr">[7]</xref> were cultured in the presence of Mitomycin-C treated J2-3T3 feeder cells as described previously <xref rid="bib8" ref-type="bibr">[8]</xref>. Stocks of A431 cells were cultured in DMEM supplemented with 10% bovine serum, penicillin and streptomycin. In clonal growth assays all cells, including A431 cells, were cultured with a feeder layer in the standard keratinocyte medium. For RNA and protein isolation the medium of all cultures was changed the day before analysis to fresh standard keratinocyte medium.</p>
        <p>Cell fractionation by rapid adhesion to 40&#xA0;&#x3BC;g/ml type I collagen was performed as described previously <xref rid="bib4 bib9" ref-type="bibr">[4,9]</xref>. For cell sorting, cells were labelled with Alexa 647 anti-human &#x3B2;1-integrin antibody (Serotec), washed and subjected to flow cytometry using a Dako MoFlo high-speed cell sorter. Fractions of 100 cells were collected from the 10% of cells expressing highest (&#x3B2;1<sup>high</sup>) and lowest (&#x3B2;1<sup>low</sup>) levels of &#x3B2;1-integrin in addition to all &#x3B2;1-integrin positive cells (All sort) and subjected to clonal analysis as described previously <xref rid="bib9" ref-type="bibr">[9]</xref>.</p>
      </sec>
      <sec>
        <label>2.2</label>
        <title>Real-time PCR analysis</title>
        <p>RNA was isolated from subconfluent cultures of cells using Tri-reagent (Invitrogen) and cDNA was generated as described previously <xref rid="bib4" ref-type="bibr">[4]</xref>. Quantitative-PCR was performed according to the manufacturer&#x2019;s instructions. The list of genes examined is described in <xref rid="app1" ref-type="sec">Supplementary material</xref>.</p>
      </sec>
      <sec>
        <label>2.3</label>
        <title>Immunostaining and antibodies</title>
        <p>Human oral SCCs, normal oral mucosa and normal skin were obtained with appropriate ethical approval. Frozen tissue sections were fixed in 0.5% paraformaldehyde for 5&#xA0;min and permeabilised for 5&#xA0;min with 0.4% Triton X-100. After blocking with 10% FCS in PBS, sections were incubated for 1&#xA0;h with antibodies diluted in 10% FCS in PBS. Cells and sections were washed with 10% FCS in PBS between incubations with primary and secondary antibodies. Antibodies were used against the following antigens: MCSP, MAP4 (9.2.27 and clone 18, BD Life Sciences), Lrig1 (gift from Dr. Satoshi Itami) and Ki67 (NCL-L-Ki67-MM1, Novocastra). Secondary antibodies conjugated with Alexa Fluor 488 or 594 were obtained from Invitrogen.</p>
        <p>Sections were mounted with Moviol and examined using a Zeiss 510 confocal microscope. For quantitative measurements sections were examined with a 20&#xD7; objective using the Ariol<sup>&#xAE;</sup> system manufactured by Applied Imaging. This generated a numerical value that reflected both staining intensity and the proportion of tissue with detectable staining.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <label>3</label>
      <title>Results</title>
      <sec>
        <label>3.1</label>
        <title>Expression of stem cell markers in human squamous cell carcinoma lines</title>
        <p>We used real-time quantitative PCR (Q-PCR) to examine gene expression levels of the 14 recently described human epidermal stem cell markers in a panel of human SCC cell lines. Five lines were derived from tumours of the oral cavity (SCC9, SCC15, SCC25, SCC27 and H376), two from facial epidermis (SCC12B.2 and SCC13) and one from the vulva (A431). RNA was also isolated from primary keratinocytes derived from normal human epidermis or oral mucosa.</p>
        <p>The SCC lines represented a range of ability to proliferate and differentiate in culture (<xref rid="fig1" ref-type="fig">Fig. 1</xref>) <xref rid="bib5 bib6 bib7 bib10" ref-type="bibr">[5&#x2013;7,10]</xref>. All lines except for SCC25 showed a 2- to 3-fold increase in colony forming efficiency and expressed lower levels of the differentiation marker, <italic>involucrin</italic>, compared to epidermal and oral keratinocytes (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). Thus, by the criteria of increased clonal growth ability and reduced involucrin expression <xref rid="bib9" ref-type="bibr">[9]</xref> the SCC lines appear to contain a higher proportion of stem cells than primary keratinocytes.</p>
        <p>We used Q-PCR to examine the expression of the 14 recently described human epidermal stem cell markers <xref rid="bib4" ref-type="bibr">[4]</xref>. Since most of the SCC lines were derived from the oral cavity, we also compared marker expression in normal oral and epidermal keratinocytes. Marker expression in keratinocytes from the two sites was similar, except for <italic>FRMD4A</italic>, an ERM domain-containing protein involved in cytoskeleton rearrangement, which was expressed at higher levels by oral keratinocytes (<xref rid="fig2" ref-type="fig">Fig. 2</xref>).</p>
        <p>The markers could be assigned to three categories, according to whether expression was decreased, increased, or variable in SCC lines compared to normal epidermal keratinocytes (<xref rid="fig2" ref-type="fig">Fig. 2</xref>). The two markers that were consistently downregulated in the SCC lines were microtubule-associated protein 4 (MAP4) and Leucine-rich repeats and immunoglobulin-like domains 1 (Lrig1) (<xref rid="fig2" ref-type="fig">Fig. 2</xref>A). MAP4 is reported to regulate cell cycle progression and to be ubiquitously expressed in proliferating cells <xref rid="bib11" ref-type="bibr">[11]</xref>, whereas Lrig1 is a negative regulator of the EGF receptor and mediates epidermal stem cell quiescence <xref rid="bib4 bib12 bib13" ref-type="bibr">[4,12,13]</xref>.</p>
        <p>The markers that were consistently upregulated in SCC lines were: <italic>FRMD4A</italic>; oxidative stress response gene 1 (<italic>OSR1</italic> or <italic>C20orf111</italic>); guanidine nucleotide binding protein 1-like protein (<italic>GNL1</italic> or <italic>HSR1</italic>), which is another stress response gene; a serine kinase, phosphorylase b kinase (<italic>PYK</italic>), and <italic>FLJ12875</italic>, a regulator of the I-kappaB kinase/NF-kappaB cascade. The upregulation was most striking in the case of <italic>FRMD4A</italic> (<xref rid="fig2" ref-type="fig">Fig. 2</xref>B); however, since expression was high in normal oral keratinocytes we conclude that elevated <italic>FRMD4A</italic> expression may reflect the site of origin rather than the malignant status of the cells.</p>
        <p>The final category of markers showed variable expression among the SCC lines (<xref rid="fig2" ref-type="fig">Fig. 2</xref>C). These were the putative ring finger protein <italic>KIAA1991</italic>; <italic>FAM120B</italic>, a protein containing domains associated with DNA repair; <italic>Rnase5</italic>, which is involved in mRNA degradation; the cell surface proteoglycan <italic>MCSP</italic>; Additional Sex Combs-like 1 (<italic>Asxl-1</italic>), which modulates polycomb and trithorax activity in <italic>Drosophila</italic>; a putative transcription factor, zinc finger protein 187 (<italic>Zfp187)</italic>; and dimethyladenosine transferase 1-like (<italic>DIMT1L</italic>), which regulates ribosome activity. It is worth noting that although MCSP is in the &#x2018;variable&#x2019; category, it was upregulated in five out of seven primary SCC lines from oral and facial epithelia.</p>
      </sec>
      <sec>
        <label>3.2</label>
        <title>Isolation of clonogenic SCC cells</title>
        <p>Human epidermal stem cells can be enriched by selecting the basal cells that express the highest levels of &#x3B2;1-integrins and adhere most rapidly to collagen <xref rid="bib9" ref-type="bibr">[9]</xref>. The SCC lines examined express similar &#x3B2;1-integrin levels to normal oral and epidermal keratinocytes <xref rid="bib14 bib15" ref-type="bibr">[14,15]</xref>. We therefore investigated whether we could enrich for clonogenic SCC cells on the basis of adhesiveness. In the case of SCC9 and SCC12B.2, the 10% of cells with the highest &#x3B2;1-integrin levels (&#x3B2;1<sup>high</sup>) had a significantly higher colony forming efficiency than all sorted cells and the 10% of cells with the lowest levels (&#x3B2;1<sup>low</sup>) cells (<xref rid="fig3" ref-type="fig">Fig. 3</xref>B and C). This was not observed for SCC27; however the colonies formed by &#x3B2;1<sup>high</sup> SCC27 cells were larger than colonies formed by &#x3B2;1<sup>low</sup> cells (<xref rid="fig3" ref-type="fig">Fig. 3</xref>D). Thus, as in normal epidermal keratinocytes, it is possible to enrich for clonogenic SCCs on the basis of high &#x3B2;1-integrin expression.</p>
        <p>To investigate whether the observed expression patterns in the SCC derived lines reflected variation within the undifferentiated, clonogenic cells, we performed Q-PCR on cDNA generated from cells fractionated on the basis of rapid adhesion to collagen, which reflects high &#x3B2;1-integrin levels (<xref rid="fig3" ref-type="fig">Fig. 3</xref>; <xref rid="bib9" ref-type="bibr">[9]</xref>). In SCC9, SCC12B.2 and SCC27 cells and oral keratinocytes the relative levels of marker expression when compared to epidermal keratinocytes were largely the same as in unfractionated cells (<xref rid="fig3" ref-type="fig">Fig. 3</xref>E). FRMD4A was upregulated in oral keratinocytes and SCC cells compared to epidermal keratinocytes. MAP4 expression was reduced in all the SCC lines and MCSP expression was variable, expression being lowest in SCC12B.2 and highest in SCC27, reflecting the changes observed in unfractionated cells. However, whereas reduced Lrig1 expression was a consistent characteristic of unfractionated cells (<xref rid="fig2" ref-type="fig">Fig. 2</xref>A), the levels of Lrig1 were remarkably similar in the enriched populations (<xref rid="fig3" ref-type="fig">Fig. 3</xref>D). Thus, clonogenic cells in SCC lines and primary keratinocytes express similar levels of Lrig1. The decrease in Lrig1 expression that characterises SCC lines may therefore be associated with expansion of the transit amplifying compartment.</p>
      </sec>
      <sec>
        <label>3.3</label>
        <title>Studies in primary tumours</title>
        <p>The data from the SCC lines make two predictions about marker expression in primary tumours: that markers that are co-expressed in the basal layer of normal epidermis are not co-expressed in SCCs; and that downregulation of MAP4 and Lrig1 is a characteristic feature of SCCs. Support for the second prediction came from analysis of a publicly available gene data set deposited at Oncomine <xref rid="bib16 bib17" ref-type="bibr">[16,17]</xref>. We found that MAP4 and Lrig1 were significantly downregulated in oral SCCs, while CD44, which has recently been reported to be a marker of tumour initiating cells in head and neck SCCs <xref rid="bib3" ref-type="bibr">[3]</xref>, and MCSP were highly upregulated (<xref rid="tbl1" ref-type="table">Table 1</xref>).</p>
        <p>To examine the sites of marker expression, we stained sections of 18 human oral SCCs, one adenoid cystic carcinoma, one lymph node metastasis of an oral SCC and two specimens of normal skin, as well as four samples of normal oral mucosa. We evaluated proliferative status by Ki67 labelling and graded the differentiation status of the tumours according to standard criteria <xref rid="bib18" ref-type="bibr">[18]</xref> (<xref rid="tbl2" ref-type="table">Table 2</xref>).</p>
        <p>Expression levels in normal and tumour tissue were scored by eye as negative (&#x2212;/+), weak (+), moderate (++) or strong (+++), based on the intensity and extent of staining (<xref rid="tbl2" ref-type="table">Table 2</xref>). We confirmed our scoring for Lrig1 expression on one sample of normal skin and five tumours, picked at random using an Applied Imaging Ariol<sup>&#xAE;</sup> system. The results were as follows (visual score in brackets): normal epidermis, 78&#xA0;&#xB1;&#xA0;3 (+++); tumour W3, 49&#xA0;&#xB1;&#xA0;6 (++); tumour P3, 21&#xA0;&#xB1;&#xA0;3 (+/&#x2212;); tumour M4, 32&#xA0;&#xB1;&#xA0;12 (+); tumour M7, 33&#xA0;&#xB1;&#xA0;10 (+/&#x2212;); tumour MET1, 17&#xA0;&#xB1;&#xA0;7 (&#x2212;). There was thus good agreement between the visual and automated scores.</p>
        <p>As reported previously <xref rid="bib4" ref-type="bibr">[4]</xref>, in normal epidermis Lrig1 and MCSP were expressed most abundantly in clusters of putative stem cells in the basal layer (brackets in <xref rid="fig4" ref-type="fig">Fig. 4</xref>A). MAP4 was expressed throughout the epidermal basal layer, expression being highest in the stem cell clusters (brackets in <xref rid="fig4" ref-type="fig">Fig. 4</xref>E). Thus, in normal epidermis Lrig1, MCSP and MAP4 were co-expressed, expression being highest in the putative SC clusters that are known to be less frequently dividing than other cells in the basal layer <xref rid="bib19 bib20" ref-type="bibr">[19,20]</xref>.</p>
        <p>As predicted, expression of Lrig1 and MAP4 was markedly decreased in tumours (<xref rid="fig4" ref-type="fig">Fig. 4</xref>B&#x2013;D, F&#x2013;H and <xref rid="tbl2" ref-type="table">Table 2</xref>). The number of cells expressing Lrig1 was reduced, as was the labelling intensity (<xref rid="fig4" ref-type="fig">Fig. 4</xref>B&#x2013;D). In tumours, there was a general reduction in MAP4 staining intensity, irrespective of differentiation status (<xref rid="fig4" ref-type="fig">Fig. 4</xref>F&#x2013;H). Moreover, low levels of MAP4 expression extended throughout the tumour mass, whereas in normal epidermis expression was confined to the basal layer.</p>
        <p>There was a tight correlation between expression of Lrig1 and the degree of tumour differentiation, as reported previously <xref rid="bib21" ref-type="bibr">[21]</xref>. Lrig1 was detected in well and moderately differentiated tumours but was markedly reduced in poorly differentiated tumours (<xref rid="fig4" ref-type="fig">Fig. 4</xref>B&#x2013;D). In 4/5 poorly differentiated tumours Lrig1 was either undetectable (&#x2212;) or expressed in only occasional cells (&#x2212;/+ or +). In one tumour most areas had only a few positive cells (+), although there was one region with more extensive staining (++). Ki67 positive cells did not express Lrig1, consistent with its role as a negative regulator of proliferation (data not shown). In well and moderately differentiated tumours Lrig1 was detected in the suprabasal layers, correlating with areas that were Ki67 negative and consistent with Lrig1 expression in normal oral mucosa (data not shown, <xref rid="tbl2" ref-type="table">Table 2</xref>).</p>
        <p>While Lrig1 and MAP4 expression was decreased in tumours, MCSP expression was upregulated (<xref rid="tbl2" ref-type="table">Table 2</xref>; <xref rid="fig4" ref-type="fig">Fig. 4</xref>B&#x2013;D). In well and moderately differentiated tumours MCSP expression was largely confined to the epithelial layer adjacent to the tumour stroma (<xref rid="fig4" ref-type="fig">Fig. 4</xref>B and C). In poorly differentiated tumours MCSP was expressed throughout the tumour (<xref rid="fig4" ref-type="fig">Fig. 4</xref>D). Whereas Lrig1 and MCSP are co-expressed in the basal layer of normal epidermis (<xref rid="bib4" ref-type="bibr">[4]</xref>; <xref rid="fig4" ref-type="fig">Fig. 4</xref>A), MCSP positive cells in tumours lacked Lrig1 expression (<xref rid="fig4" ref-type="fig">Fig. 4</xref>B&#x2013;D).</p>
      </sec>
    </sec>
    <sec>
      <label>4</label>
      <title>Discussion</title>
      <p>The panel of markers that were co-expressed in keratinocytes from normal human epidermis <xref rid="bib4" ref-type="bibr">[4]</xref> were, with the exception of FRMD4A, expressed at similar levels in keratinocyte from normal oral mucosa. Furthermore, we could enrich for clonogenic, putative stem cells on the basis of high &#x3B2;1-integrin expression and rapid adhesion to collagen in normal epidermal and oral keratinocytes, and in some of the SCC lines examined. While we did not examine inter-clonal differences within the SCC lines <xref rid="bib2" ref-type="bibr">[2]</xref>, the overall increase in colony forming efficiency and decrease in <italic>involucrin</italic> expression would indicate an expansion of the stem cell compartment. Nevertheless, these features did not correlate with increased expression of the entire panel of stem cell markers. Instead, while some markers were upregulated, two were downregulated and the remainder showed variable changes amongst the different SCC lines. In addition, basal cells in SCCs did not maintain the full complement of markers normally observed in the basal layer of oral and epidermal epithelium. Thus, there is no evidence for expansion of the normal stem cell compartment in SCCs.</p>
      <p>Downregulation of MAP4 and Lrig1 and upregulation of MCSP were consistent features of SCC lines and primary tumours. Lrig1 is known to negatively regulate EGFR signalling, thereby maintaining epidermal stem cells in a quiescent, nondividing state <xref rid="bib4 bib21" ref-type="bibr">[4,21]</xref>. It is likely that loss of Lrig1 in SCCs, which is associated with a poor prognosis <xref rid="bib21 bib22" ref-type="bibr">[21,22]</xref>, will confer a significant growth advantage in the basal layer, and lead to an expansion of committed progenitors via upregulation of EGFR signalling. Just as loss of Lrig1 will impact on a variety of signalling pathways, so will upregulation of MCSP. MCSP activates the small GTPases CDC42 and Rac1 via an integrin-mediated pathway <xref rid="bib23 bib24" ref-type="bibr">[23,24]</xref>. This is intriguing as we previously reported increased expression of the small GTPase Rac1 in SCCs as well as the tumour promoting role of altered epidermal integrin expression <xref rid="bib25 bib26" ref-type="bibr">[25,26]</xref>. Less is known about the likely consequences of loss of MAP4 in SCCs. MAP4 undergoes extensive posttranslational modifications and interacts with a number of different proteins that regulate cell cycle progression and cytokinesis <xref rid="bib11" ref-type="bibr">[11]</xref>. We speculate that reduced levels of MAP4 in SCCs facilitate more rapid cell cycle progression; however, this remains to be tested.</p>
      <p>We have demonstrated the existence of cellular heterogeneity in SCC lines, based on the expression of &#x3B2;1 integrins and ability to adhere to extracellular matrix components. In three out of four genes analysed, differences in expression observed in the clonogenic cell-enriched fraction reflected differences in the total cell population. The notable exception was Lrig1. While Lrig1 was consistently downregulated in unfractionated SCC lines and primary tumours, the levels of Lrig1 in the stem cell-enriched fractions were remarkably similar to normal oral and epidermal stem cells. This suggests that there is a subpopulation of SCC cells that are subject to negative regulation of EGFR signalling. Their existence is important clinically, because these cells will be less likely to respond to drugs that target cells with elevated EGFR signalling and may be capable of reinitiating tumour growth following therapy. In addition, it will be important to determine whether tumour initiation is a general feature of basal cells with high &#x3B2;1-integrin levels, or whether a combination of markers such as CD44, MCSP and Lrig1 will allow further enrichment.</p>
      <p>In conclusion, our data favour a model whereby during tumour development the pathways that control epithelial homeostasis are lost, particularly in the basal cell layer closest to the tumour stroma. Those markers of normal stem cells that exert a positive effect on proliferation or inhibit differentiation are upregulated, while those that normally retain the cells in a nondividing state show reduced expression. As we find out more about how different signalling pathways intersect to maintain homeostasis we will have more opportunities for restoring homeostasis in tumours.</p>
    </sec>
    <sec>
      <title>Conflict of interest</title>
      <p>The authors declare no conflict of interest.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <label>Appendix A</label>
      <title>Supplementary data</title>
      <p content-type="availability">Supplementary data associated with this article can be found, in the online version, at <ext-link xlink:href="doi:10.1016/j.canlet.2008.06.014" ext-link-type="uri">doi:10.1016/j.canlet.2008.06.014</ext-link>.</p>
    </sec>
    <sec id="app1" sec-type="supplementary-material">
      <label>Appendix A</label>
      <title>Supplementary data</title>
      <p>
        <supplementary-material content-type="local-data" id="N0x1c7b4d0N0x2d4dc50">
          <caption>
            <title>Supplementary material</title>
          </caption>
          <media xlink:href="mmc1.doc" mimetype="application" mime-subtype="msword"/>
        </supplementary-material>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p content-type="acknowledgment">We are grateful to everyone who provided us with advice, reagents or technical support, in particular Dr. Satoshi Itami, Dr. Rachael Walker, Mr. George Elia and Dr. Will Howat. We gratefully acknowledge financial support from Cancer Research UK, the Wellcome Trust, the Medical Research Council and EuroStemCell. K.B.J. is the recipient of a fellowship from the Carlsberg Foundation. The funding agencies were not involved in the study design, collection, analysis and interpretation of the results.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>[1]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Janes</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <article-title>New roles for integrins in squamous-cell carcinoma</article-title>
          <source>Nat. Rev. Cancer</source>
          <year>2006</year>
          <volume>6</volume>
          <fpage>175</fpage>
          <lpage>183</lpage>
          <pub-id pub-id-type="pmid">16498442</pub-id>
        </citation>
      </ref>
      <ref id="bib2">
        <label>[2]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Locke</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Heywood</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fawell</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mackenzie</surname>
              <given-names>I.C.</given-names>
            </name>
          </person-group>
          <article-title>Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines</article-title>
          <source>Cancer Res.</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>8944</fpage>
          <lpage>8950</lpage>
          <pub-id pub-id-type="pmid">16204067</pub-id>
        </citation>
      </ref>
      <ref id="bib3">
        <label>[3]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prince</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Sivanandan</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kaczorowski</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>G.T.</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Dalerba</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Weissman</surname>
              <given-names>I.L.</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Ailles</surname>
              <given-names>L.E.</given-names>
            </name>
          </person-group>
          <article-title>Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>973</fpage>
          <lpage>978</lpage>
          <pub-id pub-id-type="pmid">17210912</pub-id>
        </citation>
      </ref>
      <ref id="bib4">
        <label>[4]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>K.B.</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <article-title>Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>11958</fpage>
          <lpage>11963</lpage>
          <pub-id pub-id-type="pmid">16877544</pub-id>
        </citation>
      </ref>
      <ref id="bib5">
        <label>[5]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicholson</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Pei</surname>
              <given-names>X.F.</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <article-title>Expression of E-cadherin, P-cadherin and involucrin by normal and neoplastic keratinocytes in culture</article-title>
          <source>Carcinogenesis</source>
          <year>1991</year>
          <volume>12</volume>
          <fpage>1345</fpage>
          <lpage>1349</lpage>
          <pub-id pub-id-type="pmid">2070502</pub-id>
        </citation>
      </ref>
      <ref id="bib6">
        <label>[6]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rheinwald</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Beckett</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas</article-title>
          <source>Cancer Res.</source>
          <year>1981</year>
          <volume>41</volume>
          <fpage>1657</fpage>
          <lpage>1663</lpage>
          <pub-id pub-id-type="pmid">7214336</pub-id>
        </citation>
      </ref>
      <ref id="bib7">
        <label>[7]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prime</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Nixon</surname>
              <given-names>S.V.</given-names>
            </name>
            <name>
              <surname>Crane</surname>
              <given-names>I.J.</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Matthews</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Maitland</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Remnant</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Powell</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Game</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Scully</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>The behaviour of human oral squamous cell carcinoma in cell culture</article-title>
          <source>J. Pathol.</source>
          <year>1990</year>
          <volume>160</volume>
          <fpage>259</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="pmid">1692339</pub-id>
        </citation>
      </ref>
      <ref id="bib8">
        <label>[8]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gandarillas</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <article-title>c-Myc promotes differentiation of human epidermal stem cells</article-title>
          <source>Genes Dev.</source>
          <year>1997</year>
          <volume>11</volume>
          <fpage>2869</fpage>
          <lpage>2882</lpage>
          <pub-id pub-id-type="pmid">9353256</pub-id>
        </citation>
      </ref>
      <ref id="bib9">
        <label>[9]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <article-title>Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression</article-title>
          <source>Cell</source>
          <year>1993</year>
          <volume>73</volume>
          <fpage>713</fpage>
          <lpage>724</lpage>
          <pub-id pub-id-type="pmid">8500165</pub-id>
        </citation>
      </ref>
      <ref id="bib10">
        <label>[10]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rheinwald</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Beckett</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes</article-title>
          <source>Cell</source>
          <year>1980</year>
          <volume>22</volume>
          <fpage>629</fpage>
          <lpage>632</lpage>
          <pub-id pub-id-type="pmid">6160916</pub-id>
        </citation>
      </ref>
      <ref id="bib11">
        <label>[11]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andersen</surname>
              <given-names>S.S.</given-names>
            </name>
          </person-group>
          <article-title>Spindle assembly and the art of regulating microtubule dynamics by MAPs and Stathmin/Op18</article-title>
          <source>Trends Cell Biol.</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>261</fpage>
          <lpage>267</lpage>
          <pub-id pub-id-type="pmid">10856928</pub-id>
        </citation>
      </ref>
      <ref id="bib12">
        <label>[12]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gur</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Amit</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Citri</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nilsson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Amariglio</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Henriksson</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Rechavi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hedman</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wides</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Yarden</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation</article-title>
          <source>EMBO J.</source>
          <year>2004</year>
          <volume>23</volume>
          <fpage>3270</fpage>
          <lpage>3281</lpage>
          <pub-id pub-id-type="pmid">15282549</pub-id>
        </citation>
      </ref>
      <ref id="bib13">
        <label>[13]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laederich</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Funes-Duran</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Ingalla</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Carraway</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Sweeney</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases</article-title>
          <source>J. Biol. Chem.</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>47050</fpage>
          <lpage>47056</lpage>
          <pub-id pub-id-type="pmid">15345710</pub-id>
        </citation>
      </ref>
      <ref id="bib14">
        <label>[14]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugiyama</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Speight</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Prime</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <article-title>Comparison of integrin expression and terminal differentiation capacity in cell lines derived from oral squamous cell carcinomas</article-title>
          <source>Carcinogenesis</source>
          <year>1993</year>
          <volume>14</volume>
          <fpage>2171</fpage>
          <lpage>2176</lpage>
          <pub-id pub-id-type="pmid">7693359</pub-id>
        </citation>
      </ref>
      <ref id="bib15">
        <label>[15]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levy</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Broad</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Diekmann</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <article-title>Beta1 integrins regulate keratinocyte adhesion and differentiation by distinct mechanisms</article-title>
          <source>Mol. Biol. Cell</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>453</fpage>
          <lpage>466</lpage>
          <pub-id pub-id-type="pmid">10679006</pub-id>
        </citation>
      </ref>
      <ref id="bib16">
        <label>[16]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rhodes</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Kalyana-Sundaram</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mahavisno</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Varambally</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Briggs</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Barrette</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Anstet</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Kincead-Beal</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kulkarni</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Varambally</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Chinnaiyan</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles</article-title>
          <source>Neoplasia</source>
          <year>2007</year>
          <volume>9</volume>
          <fpage>166</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="pmid">17356713</pub-id>
        </citation>
      </ref>
      <ref id="bib17">
        <label>[17]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Talbot</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Estilo</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Maghami</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Sarkaria</surname>
              <given-names>I.S.</given-names>
            </name>
            <name>
              <surname>Pham</surname>
              <given-names>D.K.P.O.c.</given-names>
            </name>
            <name>
              <surname>Socci</surname>
              <given-names>N.D.</given-names>
            </name>
            <name>
              <surname>Ngai</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ghossein</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Viale</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Rusch</surname>
              <given-names>V.W.</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung</article-title>
          <source>Cancer Res.</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>3063</fpage>
          <lpage>3071</lpage>
          <pub-id pub-id-type="pmid">15833835</pub-id>
        </citation>
      </ref>
      <ref id="bib18">
        <label>[18]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sugiyama</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>F.M.</given-names>
            </name>
            <name>
              <surname>Speight</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <article-title>Integrin expression in normal, hyperplastic, dysplastic, and malignant oral epithelium</article-title>
          <source>J. Pathol.</source>
          <year>1993</year>
          <volume>169</volume>
          <fpage>235</fpage>
          <lpage>243</lpage>
          <pub-id pub-id-type="pmid">8445489</pub-id>
        </citation>
      </ref>
      <ref id="bib19">
        <label>[19]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>U.B.</given-names>
            </name>
            <name>
              <surname>Lowell</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <article-title>The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: a new view based on whole-mount labelling and lineage analysis</article-title>
          <source>Development</source>
          <year>1999</year>
          <volume>126</volume>
          <fpage>2409</fpage>
          <lpage>2418</lpage>
          <pub-id pub-id-type="pmid">10226000</pub-id>
        </citation>
      </ref>
      <ref id="bib20">
        <label>[20]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Harper</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <article-title>Stem cell patterning and fate in human epidermis</article-title>
          <source>Cell</source>
          <year>1995</year>
          <volume>80</volume>
          <fpage>83</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">7813021</pub-id>
        </citation>
      </ref>
      <ref id="bib21">
        <label>[21]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanemura</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nagasawa</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Inui</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Itami</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases</article-title>
          <source>Dermatol. Surg.</source>
          <year>2005</year>
          <volume>31</volume>
          <fpage>423</fpage>
          <lpage>430</lpage>
          <pub-id pub-id-type="pmid">15871317</pub-id>
        </citation>
      </ref>
      <ref id="bib22">
        <label>[22]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lindstrom</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Ekman</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Stendahl</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Tot</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Henriksson</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Hedman</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hellberg</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking</article-title>
          <source>Int. J. Gynecol. Cancer</source>
          <year>2008</year>
          <volume>18</volume>
          <fpage>312</fpage>
          <lpage>317</lpage>
          <pub-id pub-id-type="pmid">17624990</pub-id>
        </citation>
      </ref>
      <ref id="bib23">
        <label>[23]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eisenmann</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Keely</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Guan</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Tachibana</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Manser</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Furcht</surname>
              <given-names>L.T.</given-names>
            </name>
            <name>
              <surname>Iida</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas</article-title>
          <source>Nat. Cell. Biol.</source>
          <year>1999</year>
          <volume>1</volume>
          <fpage>507</fpage>
          <lpage>513</lpage>
          <pub-id pub-id-type="pmid">10587647</pub-id>
        </citation>
      </ref>
      <ref id="bib24">
        <label>[24]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Majumdar</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Vuori</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Stallcup</surname>
              <given-names>W.B.</given-names>
            </name>
          </person-group>
          <article-title>Engagement of the NG2 proteoglycan triggers cell spreading via rac and p130cas</article-title>
          <source>Cell Signal.</source>
          <year>2003</year>
          <volume>15</volume>
          <fpage>79</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">12401522</pub-id>
        </citation>
      </ref>
      <ref id="bib25">
        <label>[25]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Owens</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Gardner</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <article-title>Suprabasal alpha6beta4 integrin expression in epidermis results in enhanced tumourigenesis and disruption of TGFbeta signalling</article-title>
          <source>J. Cell Sci.</source>
          <year>2003</year>
          <volume>116</volume>
          <fpage>3783</fpage>
          <lpage>3791</lpage>
          <pub-id pub-id-type="pmid">12902406</pub-id>
        </citation>
      </ref>
      <ref id="bib26">
        <label>[26]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benitah</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Frye</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Glogauer</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Watt</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <article-title>Stem cell depletion through epidermal deletion of Rac1</article-title>
          <source>Science</source>
          <year>2005</year>
          <volume>309</volume>
          <fpage>933</fpage>
          <lpage>935</lpage>
          <pub-id pub-id-type="pmid">16081735</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p>Clonal growth and differentiation of human SCC lines. (A) Representative dishes of cells grown at clonal density and stained with Rhodanile B are shown. (B) Quantitation of clonal growth was based on triplicate dishes in three independent experiments&#xA0;&#xB1;&#xA0;standard deviation. (C) Analysis of <italic>Involucrin</italic> expression. Expression levels of <italic>Involucrin</italic> were determined by Q-PCR and normalised to expression of <italic>18S rRNA</italic>. Keratinocyte: epidermal keratinocytes.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>Analysis of levels of stem cell marker genes in by quantitative PCR. (A&#x2013;C) Q-PCR of normal epidermal keratinocytes (Kera), oral keratinocytes (Oral kera) and SCC lines. Expression levels of stem cell markers were normalised to expression of <italic>18S rRNA</italic>. Genes were assessed for statistically significant differences against the panel of cell lines (unfractionated) and genes categorised as either down (A) or up (B) regulated if the <italic>P</italic>-value was less than 0.01. (C) Genes with variable expression levels. Error bars represent the standard error of the mean for at least triplicate samples.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p>Selection of clonogenic SCC cells. (A) Basal cells, gated on the basis of low forward and side scatter <xref rid="bib9" ref-type="bibr">[9]</xref> were labelled with anti-&#x3B2;1-integrin antibody. The 10% of cells with highest (&#x3B2;1-integrin high) and lowest (&#x3B2;1-integrin low) integrin levels were sorted and plated out at clonal density. (B) Representative dishes of cells from the clonogenicity assay, stained with Rhodanile B. (C) Colony forming efficiency was determined as % plated cells that formed colonies. &#xB1;SEM of triplicate samples. Asterisks indicate significant differences (<italic>p</italic>&#xA0;&lt;&#xA0;0.05, two-way unpaired <italic>T</italic>-test). (D) Relative colony size was measured using Image J, and the mean was determined for all colonies&#xA0;&#xB1;&#xA0;SEM. Asterisks indicate significant differences (<italic>p</italic>&#xA0;&lt;&#xA0;0.05, two tailed Mann&#x2013;Whitney test of the median). (E) Q-PCR for <italic>MCSP</italic>, <italic>MAP4</italic>, <italic>Lrig1</italic> and <italic>Frmd4a</italic> in populations of normal oral and epidermal keratinocytes and a subset of SCC lines enriched for stem cells by rapid adhesion to collagen.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Fig. 4</label>
      <caption>
        <p>Expression of stem cell markers in human epidermis and squamous cell carcinomas. Expression of (A&#x2013;D) MCSP (red) and Lrig1 (green), (E&#x2013;H) MAP4 (red) and Ki67 (green) in epidermis (normal) and in squamous cell carcinomas of differing differentiation status (well, moderate, poor). Location of putative stem clusters is marked with horizontal lines. Panels A, E contain higher magnification inserts. Scale bars: 200&#xA0;&#x3BC;m.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <table-wrap position="float" id="tbl1">
      <label>Table 1</label>
      <caption>
        <p>A panel of selected genes known to be either involved in tumour progression and/or SC maintenance in normal tissue</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th>Gene name</th>
            <th>Entries</th>
            <th>Signal</th>
            <th><italic>P</italic>-value</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>CD44</td>
            <td>3</td>
            <td>Up</td>
            <td>6.70&#xA0;E&#x2212;14</td>
          </tr>
          <tr>
            <td>MCSP</td>
            <td>1</td>
            <td>Up</td>
            <td>2.50&#xA0;E&#x2212;04</td>
          </tr>
          <tr>
            <td>MAP4</td>
            <td>1</td>
            <td>Down</td>
            <td>5.10&#xA0;E&#x2212;06</td>
          </tr>
          <tr>
            <td>LRIG1</td>
            <td>2</td>
            <td>Down</td>
            <td>2.60&#xA0;E&#x2212;05</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>The data are derived from expression profiling of 31 oral squamous cell carcinomas and 26 samples of normal oral epithelium <xref rid="bib17" ref-type="bibr">[17]</xref>. The gene name is listed in column 1, the number of different probes detecting the gene is indicated in column 2, whether the gene is up or downregulated is listed in column 3 and the <italic>P</italic>-value for the finding is listed in column 4.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap position="float" id="tbl2">
      <label>Table 2</label>
      <caption>
        <p>Expression pattern of selected proteins in human primary SCCs as determined by indirect immunofluorescence</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th>Tumour</th>
            <th>Lrig1</th>
            <th>MCSP</th>
            <th>MAP4</th>
            <th>Differentiation</th>
            <th>Tissue</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>Foreskin</td>
            <td>+++</td>
            <td>+</td>
            <td>+++</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td>Oral mucosa</td>
            <td>++</td>
            <td>+</td>
            <td>+++</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td>P1</td>
            <td>+</td>
            <td>++</td>
            <td>+/++</td>
            <td>Poor</td>
            <td>Lateral border of tongue</td>
          </tr>
          <tr>
            <td>P2</td>
            <td>+</td>
            <td>++</td>
            <td>+</td>
            <td>Poor</td>
            <td>Tongue</td>
          </tr>
          <tr>
            <td>P3</td>
            <td>&#x2212;/+</td>
            <td>+++</td>
            <td>+</td>
            <td>Poor</td>
            <td>Maxillary antrum</td>
          </tr>
          <tr>
            <td>P4</td>
            <td>+/++</td>
            <td>+++</td>
            <td>++/ +++</td>
            <td>Poor</td>
            <td>Buccal mucosa</td>
          </tr>
          <tr>
            <td>P5</td>
            <td>&#x2212;</td>
            <td>+</td>
            <td>+/++</td>
            <td>Poor</td>
            <td>Right tonsil</td>
          </tr>
          <tr>
            <td>MP1</td>
            <td>++</td>
            <td>++</td>
            <td>++</td>
            <td>Mod/poor</td>
            <td>Dorsum tongue</td>
          </tr>
          <tr>
            <td>M1</td>
            <td>+</td>
            <td>++</td>
            <td>+</td>
            <td>Moderate</td>
            <td>Lateral border of tongue</td>
          </tr>
          <tr>
            <td>M2</td>
            <td>+</td>
            <td>++</td>
            <td>+</td>
            <td>Moderate</td>
            <td>Retromolar</td>
          </tr>
          <tr>
            <td>M3</td>
            <td>++</td>
            <td>++</td>
            <td>++</td>
            <td>Moderate</td>
            <td>Lateral border of tongue</td>
          </tr>
          <tr>
            <td>M4</td>
            <td>+</td>
            <td>+++</td>
            <td>+/++</td>
            <td>Moderate</td>
            <td>Lateral border of tongue</td>
          </tr>
          <tr>
            <td>M5</td>
            <td>+</td>
            <td>++</td>
            <td>+/&#x2212;</td>
            <td>Moderate</td>
            <td>Alveolar ridge maxilla</td>
          </tr>
          <tr>
            <td>M6</td>
            <td>+</td>
            <td>++</td>
            <td>+</td>
            <td>Moderate</td>
            <td>Buccal mucosa</td>
          </tr>
          <tr>
            <td>M7</td>
            <td>&#x2212;/+</td>
            <td>+++</td>
            <td>+</td>
            <td>Moderate</td>
            <td>Buccal mucosa</td>
          </tr>
          <tr>
            <td>M8</td>
            <td>++</td>
            <td>+++</td>
            <td>+</td>
            <td>Moderate</td>
            <td>Lateral tongue</td>
          </tr>
          <tr>
            <td>W1</td>
            <td>++</td>
            <td>++</td>
            <td>+</td>
            <td>Well</td>
            <td>Lateral border of tongue</td>
          </tr>
          <tr>
            <td>W2</td>
            <td>++</td>
            <td>+++</td>
            <td>+/++</td>
            <td>Well</td>
            <td>Buccal mucosa</td>
          </tr>
          <tr>
            <td>W3</td>
            <td>++</td>
            <td>++</td>
            <td>+</td>
            <td>Well</td>
            <td>Ventral tongue</td>
          </tr>
          <tr>
            <td>W4</td>
            <td>++</td>
            <td>++</td>
            <td>+</td>
            <td>Well</td>
            <td>Floor of mouth</td>
          </tr>
          <tr>
            <td>ACC1</td>
            <td>&#x2014;</td>
            <td>+++</td>
            <td>&#x2212;/+</td>
            <td>Adenoid cystic carcinoma</td>
            <td>Sublingual gland</td>
          </tr>
          <tr>
            <td>MET1</td>
            <td>&#x2014;</td>
            <td>++</td>
            <td>&#x2014;</td>
            <td>Poor</td>
            <td>Submandibular lymph node</td>
          </tr>
          <tr>
            <td>
              <italic>Summary</italic>
            </td>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td>Poor</td>
            <td>Down</td>
            <td>Up</td>
            <td>Down</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td>Moderate</td>
            <td>Down</td>
            <td>Up</td>
            <td>Down</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td>Well</td>
            <td>NGC</td>
            <td>Up</td>
            <td>Down</td>
            <td/>
            <td/>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>Staining intensity was scored by eye as negative (&#x2212;/+), weak (+), moderate (++) or strong (+++), based on the intensity and extent of staining. NGC: no general change.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-wrap>
</article>
